SCHEMBL2293084

SCHEMBL2293084

Cn1nc(-c2cccc(N)c2)oc1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.54
MECP2 P51608 1/20 0.49
NPC1 O15118 5/20 0.43
RAB9A P51151 4/20 0.43
KDM4E B2RXH2 4/20 0.43
MAPT P10636 4/20 0.43
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
IL2 P60568 2/20 0.43
BRD4 O60885 1/20 0.42
ATAD2 Q6PL18 1/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12377820 0.83 NOTUM (0.55) NOTUMNPC1RAB9AKDM4EMAPT
SCHEMBL2285490 0.81 NOTUM (0.54) NOTUMKDM4ESMN1; SMN2HPGDIL2
SCHEMBL17206755 0.81 NOTUM (0.54) NOTUMNPC1RAB9AKDM4EMAPT
SCHEMBL14007387 0.80 NOTUM (0.69) NOTUMNPC1RAB9AKDM4EALDH1A1
SCHEMBL2289458 0.77 NPC1 (0.56) NOTUMNPC1RAB9AKDM4EMAPT
SCHEMBL29292767 0.73 KMT2A (0.42) NOTUMMECP2NPC1RAB9AKDM4E
SCHEMBL2708056 0.72 NPC1 (0.45) MECP2NPC1RAB9AKDM4EMAPT
SCHEMBL20323164 0.71 NOTUM (0.72) NOTUMNPC1RAB9AKDM4EALDH1A1
SCHEMBL15205682 0.71 NOTUM (0.65) NOTUMKDM4ESMN1; SMN2IL2KMT2A
SCHEMBL2731450 0.71 NOTUM (0.56) NOTUMNPC1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2163554-B1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO LTD (JP) 2012-08-01 EP disclosed
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed
EP-2163554-A1 PYRIMIDODIAZEPINONE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2010-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KCNJ1, KCNJ11, ADRA1D NOTUM 3182/4885MECP2 1002/4885NPC1 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.